Company: BSX
Filing Date: 2025-02-24
Form Type: 424B2
Source: 0001104659-25-016521
Chunk: 78

Company: BOSTON SCIENTIFIC CORP
Filing Date: 2025-02-24
Form: 424B2
Chunk 78
---
 Netherlands.

The trustee is U.S. Bank Trust Company, National Association, located at One Federal Street, 3rd Floor, Boston, MA 02110.

The registrar and paying agent is U.S. Bank Europe DAC, located at Block F1, Cherrywood Business Park, Cherrywood, Dublin 18, D18 W2X7, Ireland.

#### Boston Scientific Corporation
Boston Scientific Corporation is the ultimate parent company of its consolidated subsidiaries and is the indirect parent company of AMS Europe. Boston Scientific Corporation is a Delaware corporation established under the laws of Delaware incorporated on June 22, 1979 with registered number 874815.

Details of the Board of Directors of Boston Scientific Corporation can be found on page 16 to 26 of our Proxy Statement on Schedule 14-A that is incorporated by reference herein.

In addition, on May 8, 2024, the Board of Directors appointed Cheryl Pegus, MD, MPH to be a director of Boston Scientific Corporation to hold office until the next annual meeting of stockholders. The next annual meeting of stockholders will be held on May 1, 2025. The Board of Directors further appointed Dr. Pegus to serve as a member of the Executive Compensation and Human Resources Committee and the Risk Committee of the Board of Directors. Dr. Pegus previously served as a partner at Morgan Health where, from November 2022 to May 2024, she has supported the organization’s strategic investments and broader efforts to improve the quality, affordability and equity of employer-sponsored health care. Dr. Pegus is also president of Caluent, LLC, a healthcare analytics and advisory company she has owned since 2012. Prior to that, Dr. Pegus was executive vice president of Health & Wellness at Walmart Inc., president of Consumer Health Solutions and chief medical officer for Cambia Health Solutions and chief medical officer at Walgreens. Before joining Walgreens, Dr. Pegus was the general manager and chief medical officer for SymCare Personalized Health Solutions, Inc., a diabetes-focused division of Johnson & Johnson, and held roles at Pfizer and Aetna. Dr. Pegus began her career in private practice as a cardiologist and previously served as board chair for the Association of Black Cardiologists. Dr. Pegus is currently a member of the board of directors of Concentra, a provider of occupational health services (since July 2024). Dr. Pegus serves on the board of the American Heart Association and is co-founder of A New Beat, an organization dedicated to